(Q46199518)

20 December 2017

title

Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids (English)

1 reference

20 December 2017

1 reference

2

Thomas D Dayspring

1 reference

20 December 2017

Peter Paul Toth

series ordinal

1

object named as

Peter P Toth

1 reference

20 December 2017

author name string

Gregory S Pokrywka

series ordinal

3

1 reference

20 December 2017

publication date

1 January 2009

1 reference

20 December 2017

Current Atherosclerosis Reports

published in

1 reference

20 December 2017

volume

11

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

71-79

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s11883-009-0012-z

exact match

0 references

cites work

Changes in triglyceride levels and risk for coronary heart disease in young men.

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0012-Z

Triglycerides and coronary heart disease revisited (again).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0012-Z

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0012-Z

Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0012-Z

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-009-0012-Z

Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators

21 January 2018

1 reference

12 December 2020

Mechanistic studies on metabolic interactions between gemfibrozil and statins

1 reference

12 December 2020

Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

1 reference

12 December 2020

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9.

1 reference

12 December 2020

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

12 December 2020

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

1 reference

12 December 2020

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

1 reference

12 December 2020

A chemical switch regulates fibrate specificity for peroxisome proliferator-activated receptor alpha (PPARalpha ) versus liver X receptor.

1 reference

12 December 2020

Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

1 reference

12 December 2020

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

1 reference

12 December 2020

Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor.

1 reference

12 December 2020

Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators

1 reference

12 December 2020

EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer

1 reference

12 December 2020

Blood levels of long-chain n-3 fatty acids and the risk of sudden death

1 reference

12 December 2020

Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?

1 reference

12 December 2020

Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice

1 reference

12 December 2020

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

1 reference

12 December 2020

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment

1 reference

12 December 2020

Fibrate therapy in patients with metabolic syndrome and diabetes mellitus

1 reference

12 December 2020

Triglycerides and the Risk of Coronary Heart Disease

1 reference

12 December 2020

Fatty acid regulation of gene transcription

1 reference

12 December 2020

The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism

1 reference

12 December 2020

Sterol response element-binding protein 1c (SREBP1c) is involved in the polyunsaturated fatty acid suppression of hepatic S14 gene transcription

1 reference

12 December 2020

Fibrates in 2003: therapeutic action in atherogenic dyslipidaemia and future perspectives

1 reference

12 December 2020

Control of gene expression by fatty acids

1 reference

12 December 2020

Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse

1 reference

12 December 2020

Why do omega-3 fatty acids lower serum triglycerides?

1 reference

12 December 2020

Effect of gemfibrozil on apolipoprotein B secretion and diacylglycerol acyltransferase activity in human hepatoblastoma (HepG2) cells

1 reference

12 December 2020

Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study.

1 reference

12 December 2020

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

12 December 2020

Regulation of plasma triglycerides in insulin resistance and diabetes

1 reference

12 December 2020

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

1 reference

12 December 2020

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

12 December 2020

Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial

1 reference

12 December 2020

Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study

1 reference

12 December 2020

The importance of triglycerides: results from the Prospective Cardiovascular Münster (PROCAM) Study

1 reference

12 December 2020

Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease

1 reference

12 December 2020

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group

1 reference

12 December 2020

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

1 reference

12 December 2020

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

1 reference

12 December 2020

Plasma PCSK9 concentrations correlate with LDL and total cholesterol in diabetic patients and are decreased by fenofibrate treatment.

1 reference

12 December 2020

Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.

1 reference

12 December 2020

Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study.

1 reference

12 December 2020

Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women

1 reference

12 December 2020

Plasma remnant-like lipoprotein particles or LDL-C as major pathologic factors in sudden cardiac death cases

1 reference

12 December 2020

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

12 December 2020

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial

1 reference

12 December 2020

The triglyceride issue: a view from Framingham

1 reference

12 December 2020

Mechanisms of regulation of gene expression by fatty acids

1 reference

12 December 2020

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

12 December 2020

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

12 December 2020

10.1007/S11883-009-0012-Z

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017